Table 2.
Patient and Professional Leaflets by Section (NMCD)
| |
HIReA |
FKGL |
||||
|---|---|---|---|---|---|---|
| Section name | Average | Median | Q1, Q3 | Average | Median | Q1, Q3 |
| Patient leaflet | ||||||
| Other namesa | −0.8146 | −0.9300 | −0.97, −0.64 | 19.6907 | 19.6339 | 17.81, 22.00 |
| What is it | −0.0542 | −0.1250 | −0.16, −0.07 | 5.7187 | 5.4029 | 3.36, 7.55 |
| Is it effective | −0.1388 | −0.1375 | −0.17, −0.09 | 14.1399 | 14.0728 | 12.89, 14.61 |
| How does it work | −0.0554 | −0.0850 | −0.11, 0.00 | 8.1066 | 8.1064 | 7.05, 9.11 |
| Safety concernsb | 0.0821 | 0.0025 | −0.06, 0.13 | 8.0168 | 8.0629 | 7.65, 8.43 |
| Interactions | −0.1438 | −0.1150 | −0.22, −0.02 | 12.7072 | 12.4176 | 11.41, 13.77 |
| Professional leaflet | ||||||
| Also known as | −0.7933 | −0.8875 | −0.95, −0.67 | 19.0737 | 19.1932 | 13.88, 23.58 |
| Scientific name | −0.5004 | −0.4900 | −0.78, −0.23 | 22.7578 | 24.3502 | 19.68, 27.46 |
| People use this for | −0.5892 | −0.6900 | −0.81, −0.30 | 18.2302 | 18.2151 | 15.47, 20.26 |
| Safetya | −0.9321 | −0.9450 | −0.98, −0.91 | 9.6650 | 9.8426 | 8.96, 10.42 |
| Effectiveness | −0.7129 | −0.7475 | −0.89, −0.58 | 13.2878 | 13.6454 | 12.05, 14.56 |
| Mechanism of action | −0.8779 | −0.9250 | −0.94, −0.85 | 15.0343 | 14.8974 | 14.13, 15.35 |
| Adverse reactions | −0.7717 | −0.8975 | −0.93, −0.75 | 13.1188 | 13.3519 | 12.35, 14.61 |
| Interactionsb | −0.4963 | −0.5850 | −0.63, −0.44 | 16.5631 | 16.7775 | 15.30, 17.71 |
| Dosage/administration | −0.6383 | −0.7450 | −0.79, −0.49 | 13.2847 | 13.2726 | 11.80, 13.95 |
| Editor's comments | −0.6058 | −0.5650 | −0.86, −0.48 | 13.1986 | 12.8081 | 11.55, 14.99 |
HIReA, health information readability analyzer; NMCD, Natural Medicine Comprehensive Database; Q1, first quartile; Q3, third quartile; FKGL, Flesch-Kincaid Grade Level.
a
Indicates hardest section.
b
Indicates least difficult section; evaluated 12 documents each for professional leaflets and patient leaflets.